USPTO serial 79011300
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, stroke, heart attack, hypercholesterolemia, dislipidemia, diabetes, metabolic disorders, cancer, autoimmune diseases, bacterial infection and viral infection | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2006 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 30, 2006 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 2, 2005 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 11, 2005 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 27, 2005 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 27, 2005 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 27, 2005 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Jun 30, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |